Incorrect Data in Figure and Text: In the Original Contribution entitled “Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth,” published in the November 5, 2008, issue of JAMA (2008;300:2003-2011), an inaccurate statement appeared in the text and incorrect numbers in the text and in a figure. On page 2006 in the third column, the next-to-last full sentence on the page should have read, “The number of detox patients and 12-week buprenorphine-naloxone patients providing urine at weeks 4, 8, and 12 is in Figure 2; 41 detox and 49 12-week buprenorphine-naloxone patients provided samples through week 12.” The numbers of patients with opioid-positive urine test results at weeks 4, 8, and 12 were 28, 22, and 21 in the detox group and 15, 12, and 21 in the buprenorphine-naloxone group. This is incorrectly reported in 2 places: the Results section of the abstract on page 2003 and the paragraph beginning at the end of page 2006. In Figure 2 on page 2007, the total number of patients in the Detox group should have been 46, 41, and 41, respectively. These errors had no effect on any of the results reported.
Incorrect Data in Figure and Text in: Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth. JAMA. 2009;301(8):830. doi:10.1001/jama.301.8.830